These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18974580)

  • 1. Polymorphism in methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and apolipoprotein E in hemodialysis patients.
    Al-Muhanna F; Al-Mueilo S; Al-Ali A; Larbi E; Rubaish A; Abdulmohsen MF; Al-Zahrani A; Al-Ateeq S
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):937-41. PubMed ID: 18974580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
    Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of methylenetetrahydrofolate reductase C677T polymorphism in patients with cardiovascular disease in Eastern Saudi Arabia.
    Al-Ali AK; Al-Muhana FA; Larbi EB; Abdulmohsen MF; Al-Sultan AI; Al-Maden MS; Al-Ateeq SA
    Saudi Med J; 2005 Dec; 26(12):1886-8. PubMed ID: 16380767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic variations in plasminogen activator inhibitor-1 gene and beta fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect].
    Gong R; Liu Z; Chen Z; Li L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):1-5. PubMed ID: 11836675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
    Pernod G; Bosson JL; Golshayan D; Barro C; Alloatti S; Turc-Baron C; Quarello F; Jeantet A; Von Albertini B; Forêt M; Lauren G; Cordonnier D; Piccoli G; Wauters JP;
    J Nephrol; 2004; 17(1):66-75. PubMed ID: 15151261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.
    Arikan H; Koc M; Sari H; Tuglular S; Ozener C; Akoglu E
    Ren Fail; 2007; 29(6):713-9. PubMed ID: 17763167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
    Guan LX; Du XY; Wang JX; Wang RL; Wu ZL; Jiang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):173-5. PubMed ID: 15079805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province].
    Liu SQ; Xue YM; Yang GC; He FY; Zhao XS
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):904-7. PubMed ID: 15321757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cousins with neonatal stroke, PAI-1 4G variant and MTHFR A1298C mutation.
    Golomb MR; Heiny M; Garg BP
    J Child Neurol; 2007 Jun; 22(6):753-5. PubMed ID: 17641264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of factor V, prothrombin, MTHFR, and PAI-1 genotypes in childhood cerebral thrombosis.
    Ozyurek E; Balta G; Degerliyurt A; Parlak H; Aysun S; Gürgey A
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):154-60. PubMed ID: 17456624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey.
    Sazci A; Ergul E; Kaya G; Kara I
    Cell Biochem Funct; 2005; 23(1):51-4. PubMed ID: 15386535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.
    Ksiazek P; Bednarek-Skublewska A; Buraczyńska M
    Med Sci Monit; 2004 Feb; 10(2):BR47-51. PubMed ID: 14737040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of plasma homocysteine and methylenetetrahydrofolate reductase C677T gene variant with schizophrenia: A Chinese Han population-based case-control study.
    Feng LG; Song ZW; Xin F; Hu J
    Psychiatry Res; 2009 Aug; 168(3):205-8. PubMed ID: 19564051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
    Ramón LA; Gilabert-Estellés J; Cosín R; Gilabert J; España F; Castelló R; Chirivella M; Romeu A; Estellés A
    Thromb Res; 2008; 122(6):854-60. PubMed ID: 18423526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype and allele frequency of PAI-1 promoter polymorphism in healthy subjects from the west of Mexico. Association with biochemical and hematological parameters.
    Ruiz-Quezada S; Vázquez-Del Mercado M; Parra-Rojas I; Rangel-Villalobos H; Best-Aguilera C; Sánchez-Orozco LV; Muñoz-Valle JF
    Ann Genet; 2004; 47(2):155-62. PubMed ID: 15183748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTHFR C677T polymorphism in chronic pancreatitis and pancreatic adenocarcinoma.
    Nisevic I; Dinic J; Nikolic A; Djordjevic V; Lukic S; Ugljesic M; Andjelic-Jelic M; Petrovic-Stanojevic N; Radojkovic D
    Cell Biochem Funct; 2008 Aug; 26(6):659-63. PubMed ID: 18636416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
    Eroglu A; Ulu A; Cam R; Akar N
    J BUON; 2006; 11(4):481-4. PubMed ID: 17309181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Saudi Thrombosis and Familial Thrombophilia Registry. Design, rational, and preliminary results.
    Saour JN; Shoukri MM; Mammo LA
    Saudi Med J; 2009 Oct; 30(10):1286-90. PubMed ID: 19838435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study.
    Jamison RL; Shih MC; Humphries DE; Guarino PD; Kaufman JS; Goldfarb DS; Warren SR; Gaziano JM; Lavori P;
    Am J Kidney Dis; 2009 May; 53(5):779-89. PubMed ID: 19272686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
    J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.